Nerve growth factor determines survival and death of PC12 cells by regulation of the bcl-x, bax, and caspase-3 genes

被引:61
|
作者
Rong, P
Bennie, AM
Epa, WR
Barrett, GL [1 ]
机构
[1] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia
[2] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
关键词
apoptosis; nerve growth factor; caspase; bcl-xl; bax; signal transduction;
D O I
10.1046/j.1471-4159.1999.0722294.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effects of nerve growth factor (NGF) and NGF withdrawal on expression of members of the bcl-2 family of genes and caspase-3 in PC12 cells. NGF regulated several members of the bcl-2 family and caspase-3 in a manner consistent with its effect on apoptosis in PC12 cells. Levels of bcl-xl, bcl-xs, and caspase-3 mRNAs were increased by NGF treatment. The increases in caspase-3 and bcl-xs levels should have disposed the cells toward apoptosis but were opposed by the simultaneous increase in bcl-xl level. NGF withdrawal resulted in abrupt down-regulation of bcl-xl and up-regulation of bax, favoring apoptosis. Forced expression of bcl-xl after NGF withdrawal was sufficient to prevent cell death. Cell death was rapid when NGF was withdrawn after 5 days of treatment but relatively slow when NGF was withdrawn after only 1 or 2 days of treatment. This was consistent with the reduced accumulation of caspase-3 mRNA with shorter NGF treatments. These results indicate that Bcl-xl, Bcl-xs, Bax, and caspase-3 are important regulators of apoptosis in PC12 cells. Furthermore, regulation of their mRNA levels is implicated in the signal transduction of NGF.
引用
收藏
页码:2294 / 2300
页数:7
相关论文
共 50 条
  • [21] Determining the oxidation states of manganese in PC12 and nerve growth factor-induced PC12 cells
    Gunter, KK
    Aschner, M
    Miller, LM
    Eliseev, R
    Salter, J
    Anderson, K
    Hammond, S
    Gunter, TE
    FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (02) : 164 - 181
  • [22] NEUROPROTECTIVE EFFECT OF RUTIN ON IRON INDUCED OXIDATIVE STRESS AND CYTOTOXICITY IN PC12 NEURONAL CELLS VIA BCL-2/BAX/CASPASE-3 SIGNALING PATHWAYS
    Rahman, M.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E38 - E39
  • [23] PROGRAMMED NEURONAL CELL-DEATH IN PC12 CELLS PRIMED WITH NERVE GROWTH-FACTOR
    KOIKE, T
    TANAKA, S
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 150 - 150
  • [24] The influence of Bcl-2 and FCCP on nerve growth factor deprivation induced apoptosis in PC12 cells
    Dispersyn, G
    Nuydens, R
    Geerts, H
    Borgers, M
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 10 - 10
  • [25] Effects of Transduction of the bcl-2 Gene and of Nerve Growth Factor on Apoptosis of Cultured PC12 Cells
    Han, G.
    Wei, W.
    Zhang, X.
    Lai, Zh
    Chen, Ch
    NEUROPHYSIOLOGY, 2014, 46 (04) : 338 - 342
  • [26] Nerve growth factor rescues PC12 cells from apoptosis by increasing amount of bcl-2
    Katoh, S
    Mitsui, Y
    Kitani, K
    Suzuki, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (02) : 653 - 657
  • [27] Dual effect of nerve growth factor on cell death of PC12 cells induced by serum deprivation
    Kwon, M
    Seo, S
    Chun, H
    Chung, JM
    Chung, IK
    Hur, KC
    MOLECULES AND CELLS, 2002, 13 (02) : 167 - 174
  • [28] Effects of Transduction of the bcl-2 Gene and of Nerve Growth Factor on Apoptosis of Cultured PC12 Cells
    G. Han
    W. Wei
    X. Zhang
    Zh. Lai
    Ch. Chen
    Neurophysiology, 2014, 46 : 338 - 342
  • [29] Palmitic and stearic fatty acids induce caspase-dependent and -independent cell death in nerve growth factor differentiated PC12 cells
    Ulloth, JE
    Casiano, CA
    De Leon, M
    JOURNAL OF NEUROCHEMISTRY, 2003, 84 (04) : 655 - 668
  • [30] Vasoinhibin Suppresses Nerve Growth Factor-Induced Differentiation and Survival of PC12 Pheochromocytoma Cells
    Melo, Zesergio
    Castillo, Ximena
    Moreno-Carranza, Bibiana
    Ledesma-Colunga, Maria G.
    Arnold, Edith
    Lopez-Casillas, Fernando
    Ruiz-Herrera, Xarubet
    Clapp, Carmen
    Martinez de la Escalera, Gonzalo
    NEUROENDOCRINOLOGY, 2019, 109 (02) : 152 - 164